A 12-week phase II placebo-controlled clinical trial with 255 patients with type 2 diabetes receiving KBP-042 has been completed (156), but further development of KBP-042 has been terminated by Eli Lilly and Nordic Bioscience to focus on the development of KBP-089, which is reportedly superior to KBP-042 (157, 158)
Do not use if pregnant, planning to become pregnant, or breastfeeding
Request the COA for the specific batch or lot number you are purchasing, not a generic reference COA Confirm purity testing method HPLC and mass spectrometry are the current standard for peptide blend verification Check that the vendor discloses the exact peptide-to-peptide ratio, not just the ingredient list Favor vendors offering batch-specific, third-party lab testing over in-house-only results Reconstitution and Storage Guidelines for Laboratory Use Both KLOW and GLOW ship as lyophilized powder and are reconstituted with bacteriostatic water before laboratory use, following standard peptide-handling protocols
2000 Dikbas O, Tosun M, Bes C, Tonuk SB, Aksehirli OY, Soy M
The Author(s) 2023